Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H15N5O4 |
Molecular Weight | 329.3107 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(N(CCOC(=O)C3=CN=CC=C3)C=N2)C(=O)N(C)C1=O
InChI
InChIKey=ZWIAODBBEZGVPY-UHFFFAOYSA-N
InChI=1S/C15H15N5O4/c1-18-12-11(13(21)19(2)15(18)23)20(9-17-12)6-7-24-14(22)10-4-3-5-16-8-10/h3-5,8-9H,6-7H2,1-2H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0008081 |
|||
Target ID: CHEMBL226 |
|||
Target ID: CHEMBL2094257 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7325766 |
Primary | ETOFYLLINE Approved Use1. Asthma
2. Chronic obstructive pulmonary disease
3. Chronic bronchitis
4. Emphysema
5. It can be used in premature infants who stop breathing |
||
Primary | ETOFYLLINE Approved Use1. Asthma
2. Chronic obstructive pulmonary disease
3. Chronic bronchitis
4. Emphysema
5. It can be used in premature infants who stop breathing |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity. | 2005 Aug |
|
Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
Simultaneous determination of salbutamol sulphate, bromhexine hydrochloride and etofylline in pharmaceutical formulations with the use of four rapid derivative spectrophotometric methods. | 2007 Jul 30 |
|
A liquid chromatography method for quantifying caffeine dissolution from pharmaceutical formulations into colloidal, fat-rich media. | 2010 Jul 1 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22293828
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C04AD04
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
||
|
WHO-VATC |
QC04AD04
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
236-544-2
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
ETOFYLLINE NICOTINATE
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
SN6D1V68DL
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
DB13842
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707239
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
3212
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
DTXSID30158609
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
83435
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | |||
|
m5194
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
13425-39-3
Created by
admin on Sat Dec 16 01:37:21 GMT 2023 , Edited by admin on Sat Dec 16 01:37:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD